Jack Mallick's Profile
Displaying 51-100 of 240 result(s).
Go to page:
Recent Articles
- Market Trends: Key Stocks Experience Notable Declines
- Tailored Disclosure Insights for Idox Stakeholders
- Opus IVS Achieves Milestone with $1 Billion in Calibration Revenue
- Kraig Labs Revolutionizing Eco-Luxury Apparel with Spider Silk
- Jim Cramer's Take on Stocks: What You Need to Know Now
- CustoMED Secures $6 Million to Enhance AI-Driven Surgery Solutions
- Bridger Aerospace's $331 Million Financing to Boost Fleet and Growth
- NextPlat Receives Nasdaq Extension to Meet Compliance Goals
- TASE Introduces New TA-Real Estate 35 Index for Investors
- Understanding Shareholder Disclosures Beyond the Basics
- Lucid Diagnostics Announces Upcoming Business Update Event
- Lumendi Gains CE Mark for Innovative DiLumen Products in Europe
- Lucid Diagnostics Schedules Update Call Focused on Growth Strategy
- Strategies to Generate Monthly Income from Microsoft Stocks
- Exploring the 2025-2026 Software Ecosystems for Tech Growth
- Capital Power Continues Growth with Strong Q3 Results Announcement
- Understanding the Role of AI in Press Release Creation
- Gates Industrial's Q3 2025 Report Highlights Growth Trends
- Press Releases Thrive in AI Era: Insights from 2025 Report
- Flex Reports Impressive Second Quarter Results for 2026
- Innovation and Collaboration for Saudi Healthcare Transformation
- Rigel Pharmaceuticals: Upcoming Financial Call Details Revealed
- Genpact Achieves Recognition in Forbes' Best Employers List
- Flex's Q2 Fiscal 2026 Performance Showcases Strong Results
- Johnson & Johnson Launches Epic Study on IMAAVY for gMG Treatment
- IDB Strengthens Compliance Training with Financial Integrity Focus
- Maple Leaf Foods Examines Food Safety Challenges at Symposium
- Zevra Therapeutics Showcases Commitment at Innovation Conference
- Vireo Growth and Verano Holdings Settle Legal Disputes
- HoldCo Asset Management Updates Columbia Banking Presentation
- Anavex Life Sciences' Blarcamesine: A New Hope for Alzheimer's
- Anavex Life Sciences' Blarcamesine Shows Promise in Alzheimer's Treatment
- Investigation Update: AppLovin's Shareholder Rights Under Review
- Cryptocurrency Market Update: Bitcoin and Others Await FOMC News
- Understanding Shareholder Rights for PRO, IMXI, and TCBX
- Douglas Dynamics Welcomes New Board Members for Growth
- Maravai LifeSciences Faces Legal Challenges: What Investors Need to Know
- Analyst Upgrades and Market Insights for Edwards Lifesciences
- Investment Insights: Latest Trades in Major Stocks
- Trump Coin Soars 35%: Unveiling the Surge Behind the Move
- Purple Biotech's Breakthrough in Tri-Specific Antibodies for Cancer
- Solomon Global Celebrates Major Awards at Investor Show 2025
- Equinor Reports Financial Challenges Amid Market Fluctuations
- Discovering New Lives Beneath: 30 Deep-Sea Species Uncovered
- Southern Michigan Bancorp Reports Impressive Earnings Growth
- Recognized for Excellence: A Closer Look at Rapid-Lift Serum
- Bolster AI Unveils Signals for Enhanced Threat Intelligence
- Innovative Insights from Dr. Michelle Roughton at ASPS Meeting
- Cerro de Pasco Resources Unveils Updated Offering Strategy
- Roadzen Inc. Expands Its Insurance Footprint with Major Acquisition
